Quidelortho CORP Form 4 insider transactions

NASDAQ
Director Joseph D. Wilkins Jr. reports the release of restricted stock units into common stock.
NASDAQ
Director Kenneth J. Widder reports the release of restricted stock units and subsequent ownership of common stock in QuidelOrtho Corp.
NASDAQ
Director Matthew Strobeck reports the release of restricted stock units and adjustments to beneficial ownership of QuidelOrtho Corp shares.
NASDAQ
Director Ann D. Rhoads reports the release of restricted stock units into common stock of QuidelOrtho Corp on May 24, 2024.
NASDAQ
Director Mary Lake Polan reports the release of restricted stock units and subsequent ownership of QuidelOrtho Corp shares.
NASDAQ
Director Edward L. Michael reports the release of restricted stock units into common stock on May 24, 2024.
NASDAQ
Director Evelyn S. Dilsaver reports the release of restricted stock units and subsequent ownership of 5,213 common stock shares.
NASDAQ
Director Kenneth F. Buechler reports the release of restricted stock units into common stock.
NASDAQ
Director Mary Lake Polan reports acquisition and disposal of QuidelOrtho Corp stock and restricted stock units.
NASDAQ
Director Kenneth J. Widder reports acquisition of restricted stock units in QuidelOrtho Corp.
NASDAQ
Director Joseph D. Wilkins Jr. of QuidelOrtho Corp. acquired 4,929 restricted stock units on May 22, 2024, which vest on May 22, 2025.
NASDAQ
Director Matthew Strobeck received 4,929 restricted stock units of QuidelOrtho Corp, vesting on May 22, 2025.
NASDAQ
Director Ann D. Rhoads acquired restricted stock units in QuidelOrtho Corp in lieu of cash payments for board service-related fees.
NASDAQ
Director James Prutow reports the acquisition of restricted stock units in QuidelOrtho Corp.
NASDAQ
Director Edward L. Michael acquired 4,929 restricted stock units of QuidelOrtho Corp on May 22, 2024, which vest on May 22, 2025.
NASDAQ
Director Evelyn S. Dilsaver acquired 4,929 restricted stock units of QuidelOrtho Corp on May 22, 2024, which vest on May 22, 2025.
NASDAQ
Director Kenneth F. Buechler reports acquisition of 4,929 restricted stock units in QuidelOrtho Corp.
NASDAQ
Michelle A. Hodges, SVP, General Counsel of QuidelOrtho Corp, reports the acquisition of 11,873 restricted stock units on May 13, 2024, vesting on June 30, 2025.
NASDAQ
Director Kenneth J. Widder reports the release of restricted stock units, resulting in adjustments to his beneficial ownership of QuidelOrtho Corp stock.
NASDAQ
Director Mary Lake Polan reports the release of restricted stock units and subsequent ownership of QuidelOrtho Corp common stock.
NASDAQ
Director Edward L. Michael reports the release of restricted stock units resulting in the acquisition of QuidelOrtho Corp common stock.
NASDAQ
Director Kenneth F. Buechler reports the release of restricted stock units resulting in the acquisition of QuidelOrtho Corp common stock.
NASDAQ
Louise Brandy, SVP, Chief Information Officer of QuidelOrtho Corp, reports the release of restricted stock units and subsequent tax withholding, resulting in changes to her beneficial ownership of common stock.
NASDAQ
Kenneth F. Buechler, a director at QuidelOrtho Corp, reported exercising stock options and acquiring 9,041 shares of common stock on April 12, 2024.
NASDAQ
Michael Iskra, Interim CEO of QuidelOrtho, reports the release of restricted stock units and subsequent tax withholding, affecting his beneficial ownership of company stock.
NASDAQ
QuidelOrtho's CFO, Joseph M. Busky, reports the release of restricted stock units, disposition of shares for tax obligations, and purchase of shares through the Employee Stock Purchase Plan.
NASDAQ
Robert Bujarski, Interim President, EVP & COO of QuidelOrtho Corp, reports the acquisition and disposition of company stock and restricted stock units on March 28, 2024.
NASDAQ
Werner Kroll, SVP of Research & Development at QuidelOrtho Corp, reports the acquisition and disposition of company stock and restricted stock units on March 28, 2024.
NASDAQ
Michelle Hodges, SVP and General Counsel of QuidelOrtho Corp, reports the release of restricted stock units and disposition of shares to cover tax obligations on March 28, 2024.
NASDAQ
Interim CEO of QuidelOrtho, Michael S. Iskra, reports acquisition of 21,367 restricted stock units, vesting on June 30, 2025.